Tissue Regenix Share Discussion Threads

[cyberbub] 24/2/2021 14:31

Nice share price action so far

[cyberbub] 24/2/2021 13:21

Bit quiet on here?

[cyberbub] 19/2/2021 16:56

They've trimmed a little after the big rise. No big deal IMO.

[ultrasilva] 19/2/2021 16:46

new TR1 out, Lombard Odier Asset Management

[red army] 19/2/2021 11:31

The important thing is that the chart is still in play.

[emeraldzebra] 19/2/2021 11:22

Not clear why it fell so far yesterday..... seemed it was falling on quite low volume.

[ny boy] 19/2/2021 10:39

Not one to sell, the growth hasn’t even started yet, keen buyers on the mini dips after a few got subtly mugged!

I added a few more, along with KNB,MXC,NEX & PPS all on pull backs.

[ultrasilva] 19/2/2021 10:30

@Minja19 thank you. please define considerable :)

[channel pirate] 19/2/2021 10:17

Nice to have a chartist giving us some accurate information - Thank You Minja19

[minja19] 19/2/2021 10:05

Now due a considerable pop up

[minja19] 19/2/2021 09:03

Pinged off the 8 ema at open
Tick up coming
Fingers xxd

[ultrasilva] 18/2/2021 23:07

New article on proactive investors.

Tissue Regenix ready to build on strong performance through pandemic
Philip Whiterow
14:10 Thu 18 Feb 2021

[ultrasilva] 18/2/2021 20:06

FYI

Smith & Nephew revenues and profit dropped quite a lot in 2020 - because of elective surgeries postponed. TRX revenues have not...



In 2020 we continued to strengthen Smith & Nephew through increased investment in R&D, new product launches and strategic acquisitions in our higher-growth segments. We achieved this while also managing unprecedented disruption from COVID-19. The resilience of the business and strength of the balance sheet also meant we are able to maintain our progressive dividend policy,” said Roland Diggelmann, chief executive of Smith & Nephew.

"We start 2021 with three clear priorities: to return to top-line growth and recapture momentum; to drive further operational improvement, and to continue to respond effectively to COVID-19. We will build on the progress we are starting to make in areas where we have recently invested and introduced innovation. We will again invest more in R&D and I am excited by the pipeline of new technologies approaching launch, and by the potential of our recent acquisitions,” he added.

[cyberbub] 18/2/2021 17:35

Someone was suggesting a gap at 0.75p?

[dogwalker] 18/2/2021 17:19

Which one?

[cyberbub] 18/2/2021 16:32

Gap closed?

[emeraldzebra] 18/2/2021 15:27

No objection to a set back. Flushes out weak holders and hopefully good opportunity to top up.

[cyberbub] 18/2/2021 11:17

Cerrito we know there are still Covid headwinds, bit Mr Market looks forward 6-12 months, and logically we should see a big bounce back in numbers of medical procedures later in 2021.

[minja19] 18/2/2021 11:12

The Market wants it to retest .75
That will close a gap and test the 8 ema

[cerrito] 18/2/2021 10:47

SN. today reminds us of the headwinds TRX will be facing.

[cryptotrade] 18/2/2021 09:43

interesting stock
plenty of cash

[mickhay3] 18/2/2021 07:08

Taken from LSE website -Trxhttps://m.youtube.com/watch?v=DPJrldr3VDk&feature=youtu.be

[pj84] 18/2/2021 00:44

Thanks for the link ultrasilva



Well worth a listen from 17 mins 25 to 30 mins